4.3 Article

Proteomic analysis of mitochondrial biogenesis in cardiomyocytes differentiated from human induced pluripotent stem cells

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/ajpregu.00207.2020

Keywords

cardiac differentiation; human induced pluripotent stem cells; mitochondria; proteomics

Categories

Funding

  1. National Institutes of Health (NIH) [HL067724, HL091469, HL112330, HL138720, AG023039]
  2. Leducq Foundation Transatlantic Network of Excellence [15CBD04]
  3. Busch Biomedical Grant Program
  4. New Jersey Medical School (NJMS)
  5. NIH [NS046593, 1S10OD025047-01]

Ask authors/readers for more resources

The study found that in human induced pluripotent stem cell-derived cardiomyocytes differentiated from human heart cells, an increase in mitochondrial proteins regulates metabolic pathways such as fatty acid oxidation, potentially through regulators like LonP1, IR, and Rb1. These findings may help optimize the maturation of iPSC-CMs.
Mitochondria play key roles in the differentiation and maturation of human cardiomyocytes (CMs). As human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) hold potential in the treatment of heart diseases, we sought to identify key mitochondrial pathways and regulators, which may provide targets for improving cardiac differentiation and maturation. Proteomic analysis was performed on enriched mitochondrial protein extracts isolated from hiPSC-CMs differentiated from dermal fibroblasts (dFCM) and cardiac fibroblasts (cFCM) at time points between 12 and 115 days of differentiation, and from adult and neonatal mouse hearts. Mitochondrial proteins with a twofold change at time points up to 120 days relative to 12 days were subjected to ingenuity pathway analysis (IPA). The highest upregulation was in metabolic pathways for fatty acid oxidation (FAO), the tricarboxylic acid (TCA) cycle, oxidative phosphorylation (OXPHOS), and branched chain amino acid (BCAA) degradation. The top upstream regulators predicted to be activated were peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC1-alpha), the insulin receptor (IR), and the retinoblastoma protein (Rb1) transcriptional repressor. IPA and immunoblotting showed upregulation of the mitochondrial LonP1 protease-a regulator of mitochondrial proteostasis, energetics, and metabolism. LonP1 knockdown increased FAO in neonatal rat ventricular cardiomyocytes (nRVMs). Our results support the notion that LonP1 upregulation negatively regulates FAO in cardiomyocytes to calibrate the flux between glucose and fatty acid oxidation. We discuss potential mechanisms by which IR, Rb1, and LonP1 regulate the metabolic shift from glycolysis to OXPHOS and FAO. These newly identified factors and pathways may help in optimizing the maturation of iPSC-CMs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available